Bayer World Investments B.V. — SEC Form 4 filings

SEC reporting owner CIK 1820027. 3 Form 4 filings on record with FilingPulse; latest filed 2025-03-12.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-02-15 to 2025-03-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Metagenomi, Inc. (MGX)10% owner18
Senti Biosciences, Inc. (SNTI)10% owner24

Form 4 filings — Bayer World Investments B.V.

FiledFormIssuerReported transactionsSource
2025-03-124Senti Biosciences, Inc. (SNTI)
jointly with BAYER HEALTHCARE LLC, Bayer US Holding LP, BAYER AKTIENGESELLSCHAFT
Conversion (C): 2,222,000 · Conversion (C): 2,222 (derivative)EDGAR
2024-12-114Senti Biosciences, Inc. (SNTI)
jointly with BAYER HEALTHCARE LLC, Bayer US Holding LP, BAYER AKTIENGESELLSCHAFT
Purchase (P): 2,222 (derivative) · Purchase (P): 3,333,000 (derivative)EDGAR
2024-02-154Metagenomi, Inc. (MGX)
jointly with BAYER HEALTHCARE LLC, Bayer US Holding LP, BAYER AKTIENGESELLSCHAFT
Conversion (C): 1,770,888 · Conversion (C): 1,180,592 · Conversion (C): 589,662 · Conversion (C): 509,855 · Conversion (C): 3,093,580 (derivative) @ $0 · Conversion (C): 2,062,387 (derivative) @ $0 · +2 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1820027 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →